Publicacións nas que colabora con Juan Carlos López Neila (13)

2021

  1. HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

    Journal of Biomedical Science, Vol. 28, Núm. 1

2014

  1. European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients

    HIV Medicine, Vol. 15, Núm. 7, pp. 425-430

  2. IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients

    Journal of Viral Hepatitis, Vol. 21, Núm. 3, pp. 189-197

  3. PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy

    Journal of Acquired Immune Deficiency Syndromes, Vol. 67, Núm. 2, pp. 113-119

  4. PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: A cross-sectional study

    Journal of Translational Medicine, Vol. 12, Núm. 1

2013

  1. Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients

    AIDS, Vol. 27, Núm. 2, pp. 163-173

  2. European mitochondrial haplogroups are associated with CD41 T cell recovery in HIV-infected patients on combination antiretroviral therapy

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 10, pp. 2349-2357

  3. HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy

    AIDS, Vol. 27, Núm. 8, pp. 1231-1238

  4. IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus

    Journal of Infection, Vol. 66, Núm. 2, pp. 170-178

  5. IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients

    Journal of Viral Hepatitis, Vol. 20, Núm. 5, pp. 358-366

  6. Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markers

    Journal of Acquired Immune Deficiency Syndromes, Vol. 64, Núm. 5, pp. 434-442

2012

  1. High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients

    Cytokine, Vol. 57, Núm. 1, pp. 25-29

  2. Plasma IL-6 and IL-9 predict the failure of interferon-α plus ribavirin therapy in HIV/HCV-coinfected patients

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1238-1245